Telomeres are tandem repeats of TTAGGG at the ends of chromosomes and shorten with each successful cell division, which is considered a sign of biological aging.
1,2,4-7 Short leucocyte telomere length (LTL) is a consequence of cell senescence. High oxidative stress or a pro-inflammatory state can result in telomere shortening. 8 LTL has been associated with diseases involving increased oxidative stress. 9, 10 However, its association with AF has not been addressed. A retrospective study performed by Carlquist et al 1 has
shown that subjects with paroxysmal AF rather than persistent AF or permanent AF have significantly shorter telomere length than those without AF. In the present study, we conducted a prospective cohort study to determine the association between LTL and PAF, followed by a systematic review and meta-analysis of published literature on this issue.
| ME THODS

| Prospective study
| Study design and subjects
The study was approved by the Second Hospital of Tianjin Medical University Ethics Committee. All subjects provided informed con- and January 2016. The exclusion criteria were listed as follows:
1 ≥ 80 years, 2 persistent or permanent atrial fibrillation, 3 established diagnosis of coronary artery disease by coronary angiogram, 4 dilated or hypertrophic cardiomyopathy, 5 malignant arrhythmias, 6 secondary hypertension, 7 hepatic insufficiency, 8 renal dysfunction, 9 stroke, 10 malignancy, 11 acute or chronic inflammation. Baseline characteristics including clinical profiles, laboratory parameters, and echocardiographic variables were recorded. Body mass index (BMI) was calculated from the measurement of weight and height. Patients without AF were enrolled as non-AF subjects. Paroxysmal AF (PAF)
was defined as recurrent episodes that spontaneously terminate in ≤ 7 days; this was determined by self-reporting or retrieved from the medical records (electrophysiology or 24-hour Holter monitoring) after admission.
| Leucocyte telomere length (LTL) measurements
Genomic DNA was extracted from peripheral blood leucocytes. LTL was determined with a quantitative real-time polymerase chain reaction (PCR)-based technique method. 11 It was calculated as the ratio of telomere repeat copy number (T) to single-copy gene copy number (S) (T/S ratio). All samples were processed within 24 hours. In brief,
the Ct values of telomere and single-copy gene (β-globin) were tested using the Bio-Rad DNA Engine Opticon 2 Real-time PCR Detector (Bio-Rad Ltd, Hercules, CA, USA). For telomere amplification, the PCR program was 95°C for 5 minutes, 33 cycles of 95 for 15 second, 54.3 for 1 minutes, 72 for 30 second; the forward primer sequence was 5′-CGGTTTGTTTGGGTTTGGGTTTGGGTTTGGGTTTGGGTT-3′;   and  reverse  primary  sequence  was  5′-GGC T TGCC T TACCC T TACCC T TACCC T TACCC T TACCC T-3′. For β-globin amplification, the PCR program was 95°C for for studies that examined the relationship between TL and AF. The following search terms were used: (telomere length AND atrial fibrillation). The search period was from the beginning of the database to 7th January 2018 without language restrictions. The following inclusion criteria were used: (i) the study was conducted in humans and (ii) mean difference in TL between AF and non-AF patients, or hazard ratios for AF, was reported or could be calculated from the published data.
The Newcastle-Ottawa Quality Assessment Scale (NOS) was used for quality assessment of the included studies. 13 The NOS point score system evaluated the categories of study participant selection, comparability of the results, and quality of the outcomes. The following characteristics were assessed: (i) representativeness of the exposed cohort; (ii) selection of the non-exposed cohort; (iii) ascertainment of exposure; (iv) demonstration that outcome of interest was not present at the start of study; (v) comparability of cohorts based on study design or analysis; (vi) assessment of outcomes; (vii) follow-up periods that were sufficiently long for outcomes to occur;
and (viii) adequacy of follow-up of cohorts. This scale ranged from zero to nine stars, which indicated that studies were graded as poor quality if the score was < 5, fair if the score was 5 to 7, and good if the score was > 8.
| Data extraction and statistical analysis
Data from the different studies were entered in pre-designed spreadsheets using Microsoft Excel. All abstracts were retrieved as complete manuscripts and assessed against the inclusion criteria.
The data extracted include: (i) publication details: last name of first author, publication year and locations; (ii) study design; (iii) follow-up duration; (iv) endpoint(s); (v) quality score; and (vii) characteristics of the population including sample size, gender, age and number of subjects. Two reviewers (GT and CW) reviewed each included study independently. Disagreements were resolved by adjudication with input from a third reviewer (TL).
Statistical analysis was performed using Comprehensive MetaAnalysis software (Version 2). Heterogeneity between studies was determined using Cochran's Q value, the weighted sum of squared differences between individual study effects and the pooled effect across studies, and the I 2 statistic determined from the standard chi-square test, which describes the proportion of total varianceexplained heterogeneity. I 2 > 50% was considered to reflect significant statistical heterogeneity. A fixed effects model was used if I 2 < 50%, otherwise the random-effects model using the inverse variance heterogeneity method was used. To identify the source of the heterogeneity, sensitivity analysis using the leave-one-out method was preferred. Funnel plots, Begg and Mazumdar rank correlation test and Egger's test were used to assess for possible publication bias.
| RE SULTS
| Prospective study
A total of 170 subjects who met the inclusion and exclusion criteria were finally included in our study. DNA was then extracted from all subjects. We eliminated 16 samples (8 in the non-AF group, 8 in the PAF group) since the telomere qPCR Ct values exceeded standard, and we ruled out 4 abnormal values (1 in the non-AF group, 3 in the PAF group) of the samples (relative t/s > 6). One hundred and fifty patients (54.7% for male and 45.3% for female) were eligible for further analysis, of whom 50 (62.0% for male) were diagnosed with non-rheumatic paroxysmal AF and 100 (51.0% for male) without AF.
The characteristics of the study population are listed in Table 1 .
There were differences in the baseline characteristics between the non-AF group and PAF group for heart failure (55.7% vs 78.0%, Subgroup analyses were performed for gender and age 
| Systematic review and meta-analysis
A flow diagram of the study identification and selection process is shown in Figure 2 . A total of 22 entries were retrieved from the databases, of which 5 studies met our inclusion criteria. 1,2,6,14,15 After including the data from this study, a total of 6 studies were included in the final meta-analysis. The details of the NOS quality assessment are shown in Table S1 . A total of 14794 patients with a mean age of 56.1 ± 11.8 years, 52.1% male, were included.
Telomere length tended to be shorter in patients with AF than those without AF but no statistical significance was reached (standard mean difference = −0.11 ± 0.09, P = .24; I 2 = 77%; Figure 3 ).
However, telomere shortening was not associated with a significant increase in the risk of incident AF in univariate analysis (hazard ratio: 1.34, 95% confidence interval: 0.93 to 1.93; P = .11; I 2 = 65%; Sensitivity analyses by removing one study at a time did not report significant alterations in the effective estimates (P > .05) ( Figures   S1-S4 ). Visual examination of funnel plots did not reveal significant publication bias ( Figures S5-S8 ). 
| D ISCUSS I ON
The main finding of our study is that no significant difference in leucocyte telomere length was observed between patients with paroxysmal AF (PAF) and those without PAF. No association between leucocyte telomere length and PAF was found following adjusting for age, BMI, fibrinogen, D-dimer, and left atrial diameter with an odds ratio of 1.4 (95% confidence interval: 0.15 to 14.06). However, subgroup analysis found that leucocyte telomere length values were significantly longer in male patients with PAF than in male ones without PAF (P = .026), but not in females, or when stratified by age < 60
or ≥ 60 years old. Moreover, our meta-analysis shows that leucocyte telomere length was not significantly different between AF and non-AF groups, and t/s was not a significant predictor of AF whether in univariate or multivariate analysis.
Biological aging is a significant risk factor for AF, which has been associated with increasing morbidity and mortality due to strokes. 16 The prevalence of AF increases with age 17 and the majority of patients with AF are over 65 years old. 18, 19 Telomere shortening is a consequence of inflammation and high oxidative stress, and has been associated with biological aging. Changes in telomere biology result in abnormal DNA repair. Shorter leucocyte telomere length has been linked to premature onset of coronary artery disease, 20 myocardial infarction, 21 and declining renal function in subjects with cardiovascular disease 22 and chronic heart failure.
23
A high oxidative stress environment can lead to electrophysiological and structural remodelling, 24 thereby predisposing to AF. A recent meta-analysis compared the shortest with longest third of leucocyte telomere length of 24 studies, demonstrating a pooled relative risk for coronary heart disease of 1.54. 7 Telomere length is inversely associated with higher risk of coronary heart disease, independent of conventional vascular risk factors, an association that remained consistent across study characteristics and study types.
By contrast, controversies exist as to whether shortened telomere End-stage Disease) study, a community-based cohort study, when dividing individuals into quartiles based on telomere length, the number of individuals with incident AF was inversely related to telomere length. After age-adjusted analysis, no significant relationship between short telomere length and incident AF was observed. 2 Furthermore, in the Intermountain Heart Collaborative Study, a significant association between t/s and increasing age was found.
Subjects with a history of AF had shorter telomeres compared to those without AF, a stepwise decrease in prevalence with increasing telomere length quintile. Additionally, shortened telomeres were involved with the onset of AF but were independent of its progression. 1 In another retrospective case-control study, the load-of-short telomeres and telomerase activity were much higher in cases and demonstrated a significant association with the occurrence of ICD therapy. The area under curve data indicated that these parameters were better at determining appropriate ICD therapy than left ventricular ejection fraction (LVEF). Fatal ventricular arrhythmias had a strong positive association with the number of shortest telomeres. quences: young patients and octogenerians-nonogenerians. 26, 27 In these cases, telomere length may be predictive of AF but these issues remain to be elucidated.
Of note, the mean t/s measures of telomere length of 0.28 in AF versus 0.20 in non-AF group are in or below the very lowest quintile of ranges reported in the Intermountain Heart Collaborative Study (0.21 to 3.02). 1 This would suggest much shorter telomere lengths in our study population, which was restricted to cardiology in-patients over half of whom in both groups had heart failure. The latter has previously been associated with short telomere length.
Finally, our meta-analysis of the published studies with presented data is difficult to interpret given the marked differences in patient populations and study designs. For example, confounding factors include one study when telomere data were obtained years before onset of AF 6 ; lack of comparable subgroups for paroxysmal, persistent, and permanent AF, lack of inclusion of PAF 2, 6 ; use of different methods for telomere length estimations.
| Limitations
Several limitations should be noted. Firstly, our study included only a relatively small sample size of 150 patients compared to larger studies from previous studies. Nevertheless, our findings that TL was not a significant predictor of AF are confirmed by our metaanalysis of 14 794 patients. Secondly, some differences in baseline characteristics were observed in our study, which could have confounded our results. Nevertheless, the findings of our cohort study
were not altered following multivariate adjustment. Thirdly, sleep apnea can predispose to AF 28 but this was not investigated in our study. Nevertheless, this is the first study, to the best of our knowledge, to explore the association between TL and AF, and investigate the gender difference for such associations. Future studies should examine these relationships with larger sample sizes.
| CON CLUS ION
Telomere length was similar between AF and non-AF patients and it is not an independent predictor for AF. These findings support the notion that chronological aging, but not markers of biological aging, is associated with higher risk of AF. Further studies are needed to determine the value of telomere length as a predictor or risk marker.
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